These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage. Tsvetkov L, Stern DF. Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664 [Abstract] [Full Text] [Related]
3. A predictive mathematical model of the DNA damage G2 checkpoint. Kesseler KJ, Blinov ML, Elston TC, Kaufmann WK, Simpson DA. J Theor Biol; 2013 Mar 07; 320():159-69. PubMed ID: 23266715 [Abstract] [Full Text] [Related]
4. PLK1 Activation in Late G2 Sets Up Commitment to Mitosis. Gheghiani L, Loew D, Lombard B, Mansfeld J, Gavet O. Cell Rep; 2017 Jun 06; 19(10):2060-2073. PubMed ID: 28591578 [Abstract] [Full Text] [Related]
8. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint. van Vugt MA, Gardino AK, Linding R, Ostheimer GJ, Reinhardt HC, Ong SE, Tan CS, Miao H, Keezer SM, Li J, Pawson T, Lewis TA, Carr SA, Smerdon SJ, Brummelkamp TR, Yaffe MB. PLoS Biol; 2010 Jan 26; 8(1):e1000287. PubMed ID: 20126263 [Abstract] [Full Text] [Related]
9. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. Lee HJ, Hwang HI, Jang YJ. Cell Cycle; 2010 Jun 15; 9(12):2389-98. PubMed ID: 20581453 [Abstract] [Full Text] [Related]
10. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry. Chang WL, Yu CC, Chen CS, Guh JH. Biochem Pharmacol; 2015 Mar 01; 94(1):12-21. PubMed ID: 25615907 [Abstract] [Full Text] [Related]
11. Mitotic entry: The interplay between Cdk1, Plk1 and Bora. Parrilla A, Cirillo L, Thomas Y, Gotta M, Pintard L, Santamaria A. Cell Cycle; 2016 Dec 01; 15(23):3177-3182. PubMed ID: 27831827 [Abstract] [Full Text] [Related]
12. DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation. Lemmens B, Hegarat N, Akopyan K, Sala-Gaston J, Bartek J, Hochegger H, Lindqvist A. Mol Cell; 2018 Jul 05; 71(1):117-128.e3. PubMed ID: 30008317 [Abstract] [Full Text] [Related]
13. Polo-like kinase 1 inhibits DNA damage response during mitosis. Benada J, Burdová K, Lidak T, von Morgen P, Macurek L. Cell Cycle; 2015 Jul 05; 14(2):219-31. PubMed ID: 25607646 [Abstract] [Full Text] [Related]
14. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Lossaint G, Besnard E, Fisher D, Piette J, Dulić V. Oncogene; 2011 Oct 13; 30(41):4261-74. PubMed ID: 21532626 [Abstract] [Full Text] [Related]
15. Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora. Bruinsma W, Aprelia M, García-Santisteban I, Kool J, Xu YJ, Medema RH. Oncogene; 2017 Mar 30; 36(13):1840-1848. PubMed ID: 27721411 [Abstract] [Full Text] [Related]
16. PLK1 targets CtIP to promote microhomology-mediated end joining. Wang H, Qiu Z, Liu B, Wu Y, Ren J, Liu Y, Zhao Y, Wang Y, Hao S, Li Z, Peng B, Xu X. Nucleic Acids Res; 2018 Nov 16; 46(20):10724-10739. PubMed ID: 30202980 [Abstract] [Full Text] [Related]